DK355079A - Fremgangsmaade til fremstilling af et injicerbart praeparat med forbedret stabilitet - Google Patents
Fremgangsmaade til fremstilling af et injicerbart praeparat med forbedret stabilitetInfo
- Publication number
- DK355079A DK355079A DK355079A DK355079A DK355079A DK 355079 A DK355079 A DK 355079A DK 355079 A DK355079 A DK 355079A DK 355079 A DK355079 A DK 355079A DK 355079 A DK355079 A DK 355079A
- Authority
- DK
- Denmark
- Prior art keywords
- preparing
- procedure
- improved stability
- injectable preparation
- injectable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7834610 | 1978-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK355079A true DK355079A (da) | 1980-02-26 |
Family
ID=10499274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK355079A DK355079A (da) | 1978-08-25 | 1979-08-24 | Fremgangsmaade til fremstilling af et injicerbart praeparat med forbedret stabilitet |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0008525A3 (xx) |
| JP (1) | JPS5533487A (xx) |
| AU (1) | AU530249B2 (xx) |
| CA (1) | CA1130210A (xx) |
| DK (1) | DK355079A (xx) |
| IL (1) | IL58097A (xx) |
| NZ (1) | NZ191368A (xx) |
| PT (1) | PT70100A (xx) |
| ZA (1) | ZA794484B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2469179A1 (fr) * | 1979-11-08 | 1981-05-22 | Beecham Group Ltd | Composition pharmaceutique pour injection renfermant une penicilline |
| EP0052962B1 (en) * | 1980-11-20 | 1984-05-09 | Beecham Group Plc | Pharmaceutical compositions containing two beta-lactam derivatives |
| FI871447A (fi) * | 1986-04-07 | 1987-10-08 | Bristol Myers Co | Stabila injicerbara antivomitiva kompositioner. |
| WO1992015299A1 (en) * | 1991-03-05 | 1992-09-17 | Bloom, Leonard | Topical treatment of acne |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE536866A (xx) * | ||||
| GB1508977A (en) * | 1974-04-20 | 1978-04-26 | Beecham Group Ltd | Beta-lactam antibiotic from streptomyces clavuligerus |
| GB1463563A (en) * | 1974-10-10 | 1977-02-02 | Beecham Group Ltd | Pharmaceutical compositions |
| GB1518722A (en) * | 1976-05-05 | 1978-07-26 | Beecham Group Ltd | Pharmaceutical composition containing cephalosporin compounds |
-
1979
- 1979-08-16 EP EP79301671A patent/EP0008525A3/en not_active Ceased
- 1979-08-21 NZ NZ191368A patent/NZ191368A/xx unknown
- 1979-08-22 PT PT70100A patent/PT70100A/pt unknown
- 1979-08-23 IL IL58097A patent/IL58097A/xx unknown
- 1979-08-23 AU AU50224/79A patent/AU530249B2/en not_active Ceased
- 1979-08-24 CA CA334,380A patent/CA1130210A/en not_active Expired
- 1979-08-24 JP JP10803379A patent/JPS5533487A/ja active Pending
- 1979-08-24 ZA ZA00794484A patent/ZA794484B/xx unknown
- 1979-08-24 DK DK355079A patent/DK355079A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL58097A0 (en) | 1979-12-30 |
| EP0008525A2 (en) | 1980-03-05 |
| NZ191368A (en) | 1982-05-25 |
| AU530249B2 (en) | 1983-07-07 |
| ZA794484B (en) | 1980-08-27 |
| IL58097A (en) | 1982-03-31 |
| CA1130210A (en) | 1982-08-24 |
| EP0008525A3 (en) | 1980-05-28 |
| JPS5533487A (en) | 1980-03-08 |
| PT70100A (en) | 1979-09-01 |
| AU5022479A (en) | 1980-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
| DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
| DK147426C (da) | Fremgangsmaade til fremstilling af solplisse med paatrykte forkanter | |
| DK446179A (da) | Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer | |
| DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
| DK7579A (da) | Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid | |
| DK19579A (da) | Fremgangsmaade til fremstilling af spirothienohydantoinderivater | |
| DK294880A (da) | Fremgangsmaade til fremstilling af n-phosphonomethylglycin | |
| DK442476A (da) | Fremgangsmade til fremstilling af pyrimidinforbindelser | |
| DK413780A (da) | Fremgangsmaade til fremstilling af d-6-n-propylergoliner | |
| DK374579A (da) | Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat | |
| DK138879A (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
| DK149432C (da) | Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methylester | |
| DK159195C (da) | Fremgangsmaade til fremstilling af stabile, injicerbare oploesninger af et oxytetracyclinchelat | |
| DK330279A (da) | Fremgangsmaade til fremstilling af soem | |
| DK136481A (da) | Fremgangsmaade til fremstilling af et insulinforstadium | |
| DK154926C (da) | Fremgangsmaade til fremstilling af en etomidatholdig infusionsvaeske | |
| DK177680A (da) | Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner | |
| DK355079A (da) | Fremgangsmaade til fremstilling af et injicerbart praeparat med forbedret stabilitet | |
| DK157850C (da) | Fremgangsmaade til fremstilling af 7-acylindolin-2-oner | |
| DK250679A (da) | Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin | |
| DK12879A (da) | R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate | |
| DK464075A (da) | Fremgangsmade til brygning af ol med forbedret stabilitet | |
| DK154771C (da) | Fremgangsmaade til fremstilling af phosphorpentasulfid med bestemt reaktivitet | |
| DK362379A (da) | Fremgangsmaade til fremstilling af alfa-alkyl-o-oxybenzylaminderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |